NASHVILLE, Tenn. -- Racial biases persist in the use of pulse oximetry devices for patients with acute hypoxemic respiratory failure (AHRF) requiring very high levels of oxygen support, a ...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the findings of an abstract presented last Saturday at the Society for Technology in Anesthesia 2022 Annual Meeting, which ...
The UCSF Hypoxia Laboratory and UCSF Center for Health Equity in Surgery and Anesthesia (CHESA) are formally launching the Open Oximetry Project, a multi-year initiative to improve access to safe ...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the results of a study published in Pneumonia in which independent researchers in New Delhi, India, investigated the ...
Acknowledging the disparity in pulse oximetry implicates a $2 billion industry that has faced stricter regulations in recent years in an attempt to address bias in the development and testing of these ...
Obstructive sleep apnea (OSA) is a common sleep disorder in the U.S. affecting tens of millions, with estimates ranging from ...
Given the extent of disagreement among observers regarding the color of infants observed under identical conditions (i.e., via video recording), the study authors concluded that real-world visual ...
A Food and Drug Administration advisory committee met Friday to figure out ways to make pulse oximeters more accurate when doing readings on darker skin both in hospitals and at home, after research ...
If you’ve had a checkup, a medical professional may have clipped a device to your finger to measure your oxygen saturation (SpO2) and pulse. Until last year, that was my only experience with such ...
About a year after beginning its full market launch, Masimo’s W1 smartwatch can now be used as a medical device in the U.S. The wearable device has earned FDA clearance for its medical applications, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results